Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.69 is 40% above its 5-year average of -1.15, near the high end of its 5-year range (-1.70–-0.67).
2.82% above its 12-month average of -0.71.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 28 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.69
EARNINGS PER SHARE (EPS) AVG TTM
-0.71
EARNINGS PER SHARE (EPS) AVG 3Y
-1.04
EARNINGS PER SHARE (EPS) AVG 5Y
-1.15
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.82%
CURRENT VS 3Y AVG
+33.65%
CURRENT VS 5Y AVG
+39.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Milestone Pharmaceuticals Inc.
Market Cap
$95.14M
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.71
3Y Avg
-1.04
5Y Avg
-1.15
Market Cap
$97.14M
Earnings Per Share (EPS)
-10.01
TTM Avg
-10.93
3Y Avg
-75.63
5Y Avg
-58.09
Market Cap
$92.69M
Earnings Per Share (EPS)
-0.91
TTM Avg
0.49
3Y Avg
1.23
5Y Avg
1.23
Market Cap
$97.90M
Earnings Per Share (EPS)
-1.48
TTM Avg
-3.50
3Y Avg
-21.30
5Y Avg
-30.60
Market Cap
$97.94M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$99.62M
Earnings Per Share (EPS)
-3.50
TTM Avg
-4.18
3Y Avg
-3.30
5Y Avg
-7.15
Market Cap
$90.64M
Earnings Per Share (EPS)
7.80
TTM Avg
-6.12
3Y Avg
-10.92
5Y Avg
-10.81
Market Cap
$90.37M
Earnings Per Share (EPS)
-0.50
TTM Avg
-2.50
3Y Avg
-2.81
5Y Avg
-2.25
Market Cap
$90.20M
Earnings Per Share (EPS)
0.08
TTM Avg
-0.19
3Y Avg
-0.36
5Y Avg
-0.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $95.14M | -0.69 | -0.71 | -1.04 | -1.15 |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | -10.01 | -10.93 | -75.63 | -58.09 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.69M | -0.91 | 0.49 | 1.23 | 1.23 |
| PolyPid Ltd. (PYPD)vs › | $97.90M | -1.48 | -3.50 | -21.30 | -30.60 |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | -3.50 | -4.18 | -3.30 | -7.15 |
| Rallybio Corporation (RLYB)vs › | $90.64M | 7.80 | -6.12 | -10.92 | -10.81 |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | -0.50 | -2.50 | -2.81 | -2.25 |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 0.08 | -0.19 | -0.36 | -0.27 |
| Equillium, Inc. (EQ)vs › | $89.78M | -0.26 | -0.31 | -0.33 | -0.76 |
Trailing EPS (TTM)
$-0.69
Forward EPS (Est.)
$-0.84
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.75 |
| 2024-12-31 | -0.67 |
| 2023-12-31 | -1.39 |
| 2022-12-31 | -1.35 |
| 2021-12-31 | -1.02 |
| 2020-12-31 | -1.70 |
| 2019-12-31 | -3.50 |
| 2018-12-31 | -0.98 |
| 2017-12-31 | -0.34 |
